etiron has been researched along with Ischemic Attack, Transient in 1 studies
etiron: a nitric oxide synthase inhibitor; RN given refers to parent cpd; structure
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakashima, MN | 1 |
| Ajiki, K | 1 |
| Nakashima, K | 1 |
| Takahashi, M | 1 |
1 other study available for etiron and Ischemic Attack, Transient
| Article | Year |
|---|---|
Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice.
Topics: Animals; Anxiety; Carotid Arteries; Enzyme Inhibitors; Exploratory Behavior; Indazoles; Interpersona | 2003 |